We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$108M
AUM Growth
+$3.84M
Cap. Flow
+$45.7K
Cap. Flow %
0.04%
Top 10 Hldgs %
25.92%
Holding
106
New
6
Increased
24
Reduced
45
Closed
4

Sector Composition

Rank Sector Weight
1 Financials 22.85%
2 Healthcare 19.94%
3 Energy 15.81%
4 Consumer Discretionary 12.41%
5 Industrials 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBBK icon
1
The Bancorp
TBBK
$2.79B
$5.33M 4.92%
163,340
-1,490
-0.9% -$45.9K
NVR icon
2
NVR
NVR
$17.2B
$3.54M 3.27%
558
CVX icon
3
Chevron
CVX
$388B
$3.16M 2.91%
20,063
-59
-0.3% -$9.46K
MRK icon
4
Merck
MRK
$324B
$2.42M 2.23%
20,933
-603
-3% -$68.5K
LEN icon
5
Lennar Class A
LEN
$20.4B
$2.3M 2.12%
18,995
-338
-2% -$36.9K
MGM icon
6
MGM Resorts International
MGM
$11.7B
$2.26M 2.08%
51,475
-251
-0.5% -$10.7K
GE icon
7
GE Aerospace
GE
$367B
$2.22M 2.05%
25,366
-2,631
-9% -$213K
ABBV icon
8
AbbVie
ABBV
$458B
$2.2M 2.02%
16,292
-96
-0.6% -$14.1K
COP icon
9
ConocoPhillips
COP
$147B
$2M 1.84%
19,300
-700
-4% -$71.9K
MMM icon
10
3M
MMM
$89B
$1.96M 1.81%
23,430
+1,976
+9% +$168K
BMY icon
11
Bristol-Myers Squibb
BMY
$127B
$1.94M 1.79%
30,396
-203
-0.7% -$13.6K
LLY icon
12
Eli Lilly
LLY
$1.07T
$1.93M 1.78%
4,121
-184
-4% -$77.2K
TFIN icon
13
Triumph Financial Inc
TFIN
$1.83B
$1.87M 1.72%
30,765
+7,071
+30% +$389K
FANG icon
14
Diamondback Energy
FANG
$57.6B
$1.86M 1.72%
14,161
-124
-0.9% -$16.6K
DOC
15
DELISTED
PHYSICIANS REALTY TRUST
DOC
$1.79M 1.65%
128,122
+10,612
+9% +$151K
PXD
16
DELISTED
Pioneer Natural Resource Co.
PXD
$1.73M 1.6%
8,359
-76
-0.9% -$16K
OGN icon
17
Organon & Co
OGN
$3.55B
$1.73M 1.59%
82,912
+17,197
+26% +$374K
CTRA
18
DELISTED
Coterra Energy
CTRA
$1.68M 1.55%
66,480
-552
-0.8% -$13.7K
CATC
19
DELISTED
CAMBRIDGE BANCORP
CATC
$1.67M 1.54%
30,721
+14,017
+84% +$781K
VTRS icon
20
Viatris
VTRS
$20.1B
$1.67M 1.54%
166,896
+26,085
+19% +$249K
GILD icon
21
Gilead Sciences
GILD
$161B
$1.65M 1.53%
21,468
-784
-4% -$62.5K
EOG icon
22
EOG Resources
EOG
$78B
$1.65M 1.52%
14,391
-129
-0.9% -$14.7K
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.64M 1.52%
4,819
PFE icon
24
Pfizer
PFE
$140B
$1.64M 1.51%
44,614
-280
-0.6% -$10.9K
TROW icon
25
T. Rowe Price
TROW
$25B
$1.61M 1.49%
14,385
+3,203
+29% +$351K

Similar funds

Sippican Capital Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Sippican Capital Advisors held 106 positions worth $108M, up 3.7% from $105M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sippican Capital Advisors's Q2 2023 filing shows 6 new, 24 increased, 45 reduced and 4 closed positions. Its largest new stake was Veritex Holdings: 20,192 shares worth $362K. The largest sale was Triton International Limited, an estimated $1.82M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Energy.

  • Sippican Capital Advisors's largest Q2 2023 buy was Veritex Holdings: 20,192 shares worth $362K.
  • Sippican Capital Advisors added most to CAMBRIDGE BANCORP in Q2 2023, an estimated $781K increase.
  • Sippican Capital Advisors's biggest Q2 2023 reduction was Walt Disney, cutting an estimated $475K.
  • Sippican Capital Advisors fully exited Triton International Limited in Q2 2023, selling an estimated $1.82M.
  • Sippican Capital Advisors's ten largest holdings make up 26% of its $108M portfolio in Q2 2023.
  • Sippican Capital Advisors opened 6 new positions and closed 4 in Q2 2023.
  • Sippican Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $108M.

Based on Sippican Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.